Epidemiology and Clinical Presentation
Thromboangiitis obliterans presents with a very specific and recognizable patient profile. Epidemiological data indicate that the pathology occurs almost exclusively in male smokers. The onset of the disease typically occurs in young to middle adulthood—around the age of 35. In clinical practice, the development of this condition is very frequently combined with manifestations of superficial migrating thrombophlebitis, which further worsens the state of the vascular bed.
The symptoms of the disease directly stem from progressive peripheral circulatory disorders in the affected areas. Patients regularly report intense pain in the extremities. A classic clinical marker of ischemia in this pathology is intermittent claudication—a specific pain syndrome that forces a person to periodically stop while walking due to an acute lack of tissue perfusion.
Etiology and Pathogenesis
Despite being studied for a long time, the exact cause of thromboangiitis obliterans remains unknown. The scientific community actively discusses the hypothesis of a potential infectious agent acting as the primary trigger, though exact confirmations have yet to be found.
The pathogenesis of the disease is characterized by a unique sequence of events. It is generally accepted that the inflammatory process initially originates not within the vessel wall tissues, but directly inside the formed thrombi. Only afterwards does the aggressive inflammation spread by contact to the vascular wall.
The main targets of the pathology are medium- and small-sized arteries. Large vascular trunks are involved only in rare cases. As the disease progresses, inflammation is not limited exclusively to the arterial bed; it steadily spreads to accompanying veins and adjacent nerve trunks. The outcome of such extensive involvement is the development of pronounced fibrosis in all surrounding tissues.
Morphological Findings and Complications
Macroscopic and microscopic examination of the affected tissues reveals frequent thrombus formation within the vascular lumen. A key morphological feature of Buerger disease is the presence of specific microabscesses within these thrombi.
The structure of such a microabscess has clear boundaries. Peripherally, it is surrounded by a dense cellular wall consisting of epithelioid cells and fibroblasts. Among them, Langhans giant cells are prominent, and their presence serves as an important diagnostic sign.
During the natural organization of the thrombus, these microabscesses do not remain unchanged—they are gradually replaced by newly formed granulation tissue, ultimately leading to sclerosis and persistent luminal obliteration.
It is important to emphasize a critical differential diagnostic criterion: necrosis of the vessel wall itself and damage to the internal elastic lamina are not characteristic of thromboangiitis obliterans. The disease itself is characterized by a remitting course. This means that histological examination can simultaneously reveal completely different stages of the pathological process in various segments of the vascular bed—from fresh thrombi to areas of dense fibrosis.
The main and most formidable complication of long-standing thromboangiitis obliterans is the development of gangrene of the extremities, which is associated with a critical drop in blood flow due to complete vascular obliteration.